A comparison of drug‐eluting stent and coronary artery bypass grafting in mildly to moderately ischemic heart failure

Aims The best revascularization strategy for patients with ischaemic heart failure (IHF) remains unclear. Current evidence and guidelines mainly focus on patients with severe ischaemic heart failure (ejection fraction [EF] 

Saved in:
Bibliographic Details
Published in:ESC Heart Failure 2022-06, Vol.9 (3), p.1749-1755
Main Authors: Wang, Kun, Wang, Le, Cong, Hongliang, Zhang, Jingxia, Hu, Yuecheng, Zhang, Yingyi, Zhang, Rui, Li, Wenyu, Qi, Wei
Format: Article
Language:English
Subjects:
Angioplasty
Cardiovascular disease
Clinical outcomes
Coronary Artery Bypass
Coronary artery bypass grafting
Coronary vessels
Creatinine
Diabetes
Drug-Eluting Stents
Drug‐eluting stent implantation
Ejection fraction
Heart attacks
Heart failure
Heart Failure - surgery
Heart surgery
Humans
Hypertension
Ischaemic heart failure
Ischemia
Medical prognosis
Original
Patients
Percutaneous Coronary Intervention
Population
Revascularization
Stents
Stroke
Stroke Volume
Thoracic surgery
Variables
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims The best revascularization strategy for patients with ischaemic heart failure (IHF) remains unclear. Current evidence and guidelines mainly focus on patients with severe ischaemic heart failure (ejection fraction [EF] 
ISSN:2055-5822
2055-5822
DOI:10.1002/ehf2.13852